CONTINGENT RECEIVABLE (Details Narrative) |
Nov. 10, 2025
USD ($)
$ / shares
|
Dec. 31, 2025
USD ($)
|
Nov. 10, 2025
CAD ($)
$ / shares
|
Jul. 11, 2025
$ / shares
|
Jul. 11, 2025
$ / shares
|
Apr. 28, 2025
$ / shares
|
Apr. 28, 2025
$ / shares
|
Mar. 31, 2025
USD ($)
|
Jan. 09, 2025
$ / shares
|
Jan. 09, 2025
$ / shares
|
Mar. 31, 2024
USD ($)
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
| Transfer amount | $ 70,449 | $ 68,080 | $ 64,936 | ||||||||
| Share price at grant date | (per share) | $ 6.946 | $ 9.50 | $ 8.64 | $ 12.00 | $ 29.55 | $ 42.39 | |||||
| Sharing Agreement [Member] | |||||||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
| Agreement description | The Sharing Agreement calculates each additional tranche, as the Transfer Amount of CAD$1,209,091 ($882,152 at balance sheet rate) minus the difference between the Benchmark Price of CAD$7.75 ($5.65 at balance sheet rate) and the trailing 20-day Value Weighted Average Price times 164,223 (Transfer Amount – ((Benchmark Price – 20-day VWAP)*164,223). The Company is responsible to pay 8% brokerage fee with each tranche | ||||||||||
| Transfer amount | $ 882,152 | $ 1,209,091 | |||||||||
| Share price at grant date | (per share) | $ 5.65 | $ 7.75 | |||||||||
| Brokerage fee percentage | 8.00% | 8.00% |